Levothroid

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Levothroid

Property Description
Active Ingredient Levothyroxine Sodium
Form Oral Tablet
Pharmacological Class Thyroid Agent / Endocrine Agent
General Purpose Hormone Replacement
Origin Synthetic (Chemically synthesized T4)

Identity and Classification: A Synthetic Hormone

Levothroid is a prescription-only medication classified as a Thyroid agent, which belongs to the wider pharmacological category of Endocrine agents. Its primary role is Thyroid hormone replacement therapy, substituting for a crucial naturally occurring substance that the body is unable to generate in sufficient quantities. The medication is prepared for Oral administration as a standardized Oral tablet, a traditional and well-established dosage form for systemic delivery.

Composition: Levothyroxine Sodium

The sole Active ingredient in Levothroid is Levothyroxine Sodium, which is the synthetic equivalent of the naturally produced hormone L-thyroxine, also known as T4 (Tetraiodothyronine). This synthetic derivation, which is clinically recognized for its stability and consistency, provides a precise dose of the precursor hormone. As a single (Monotherapy) product, Levothroid differs from older animal-derived preparations because it allows the body's natural systems to regulate the conversion of T4 into the more potent T3 hormone.

General Purpose: Restoring Metabolic Balance

Levothroid's general purpose is to restore the normal balance of thyroid hormones, thereby supporting Metabolic function throughout the body. The drug works by replicating the essential Physiological actions of the endogenous hormone, which are necessary for regulating energy expenditure and cell maintenance. This medication is effective as a hormone substitute when a deficiency is present, which helps resolve the systemic discomforts associated with hormonal insufficiency.

What side effects are possible with Levothroid?

Possible Side Effects and Safety Information

Adverse reactions associated with Levothroid (levothyroxine sodium) are primarily symptoms of hyperthyroidism and generally occur as a result of therapeutic overdosage. These reactions often mimic the effects of an overactive thyroid gland.

Commonly Reported Adverse Reactions (Related to Overdosage):

  • Cardiovascular: Palpitations, tachycardia, arrhythmias, increased pulse and blood pressure, angina.
  • Central Nervous System: Headache, nervousness, irritability, insomnia, tremors, hyperactivity.
  • Other: Diarrhea, vomiting, abdominal cramps, increased appetite, weight loss, heat intolerance, fever, excessive sweating, muscle weakness, muscle spasm, and changes in the menstrual cycle.

Serious Warnings and Precautions:

  • Black Box Warning: Levothroid is not indicated for the treatment of obesity or for weight loss. Doses greater than those required for thyroid replacement are ineffective for weight reduction in euthyroid patients and may cause serious or even life-threatening toxicity, particularly when used with sympathomimetic amines.
  • Cardiac Risk: Overtreatment with levothyroxine may cause or worsen cardiac adverse reactions, including arrhythmias, tachycardia, myocardial ischemia, and infarction, particularly in the elderly and in patients with pre-existing cardiovascular disease. Initial dosing in these populations is typically lower to minimize risk.
  • Contraindications: The medication is contraindicated in patients with untreated subclinical or overt hyperthyroidism, acute myocardial infarction, and uncorrected adrenal insufficiency. Treatment of adrenal insufficiency must precede the initiation of Levothroid.
  • Long-Term Use: Over-replacement is associated with a decrease in bone mineral density, increasing the risk of fractures, especially in postmenopausal women.
  • Diabetic Patients: Levothyroxine therapy may worsen glycemic control, requiring careful monitoring and potential adjustment of antidiabetic agent dosage.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Levothyroid, which contains levothyroxine sodium, produces clinical signs and symptoms consistent with hyperthyroidism or thyrotoxicosis due to excessive hormonal action. Doses beyond the normal hormonal requirement range may produce serious or even life-threatening manifestations of toxicity.

Documented Overdose Manifestations

The most commonly documented clinical signs associated with overdosage affect the cardiovascular and central nervous systems. These include arrhythmias, tachycardia (rapid heart rate), palpitations, angina pectoris, tremors, nervousness, insomnia, headache, excessive sweating, and heat intolerance. Severe manifestations include myocardial infarction and cardiac arrest, especially in vulnerable patients.

Required Emergency Actions

Immediate medical attention is required for any suspected overdose or when signs of thyrotoxicosis are observed. Given the long half-life of levothyroxine, clinical effects may be delayed by several days, making continuous hospital monitoring necessary for severe cases.

Treatment is officially defined as symptomatic and supportive. No specific antidote is known or documented. Supportive measures may involve administering activated charcoal to reduce absorption, using beta-blockers to manage cardiovascular effects, and monitoring of thyroid function tests (e.g., TSH, T4 levels).

Population-Specific Notes

The official labeling notes that elderly patients and those with underlying cardiovascular disease are at an increased risk of serious cardiac complications when exposed to excessive levothyroxine. In infants, chronic over-replacement is associated with craniosynostosis and premature closure of the epiphyses.

Therapeutic Uses of Levothroid

What Levothroid Treats: Main Uses and Benefits

Levothroid, which contains the active ingredient levothyroxine, is a prescription medication generally applied in managing conditions involving episodic or fluctuating manifestations of thyroid hormone deficiency. Its primary therapeutic use involves supporting patients during episodes of heightened discomfort linked to thyroid hormone deficiency.

The medication is commonly used to help with managing conditions presenting with acute episodes of hypothyroidism. The conditions managed often fall into categories of thyroid hormone deficiency, including primary, secondary, and tertiary classifications. Hypothyroidism is a condition presenting with systemic or localized discomfort where functional stability becomes affected due to deficiency.

The use of this therapy is relevant for easing symptom clusters that may become intense or disruptive, such as symptoms related to systemic imbalance. Applied during phases of increased distress or discomfort, the therapy helps ease the overall symptom burden and may assist with maintaining functional stability.

“The therapy offers symptomatic relief that helps patients cope more steadily during episodes of heightened discomfort.”

The medication may also be part of symptomatic management in situations involving certain thyroid conditions, such as thyrotropin-dependent well-differentiated thyroid cancer.


Quick Fact: Relief for Symptoms related to systemic imbalance

Eligibility and Restrictions for Use

Official Eligibility Rules for Levothroid Use

Regulatory agencies define the specific populations allowed to use Levothroid (Levothyroxine Sodium) and those who are strictly excluded. The medication is established for use in both adult and pediatric patients, including neonates and infants, who require thyroid hormone replacement therapy.

Contraindications

The medicine is contraindicated and must not be used in several specific patient groups, as defined in official labeling:

  • Patients with acute myocardial infarction, acute myocarditis, or acute pancarditis.
  • Individuals with untreated thyrotoxicosis of any cause.
  • Patients with uncorrected adrenal insufficiency (glucocorticoid treatment must be initiated first).
  • Use is prohibited for the sole purpose of obesity or weight loss in euthyroid individuals.

Conditional Use and Restrictions

Use is acceptable during pregnancy and lactation, but treatment should be continued and may require dosage adjustment. Special caution and a lower starting dose are required for elderly patients and individuals with underlying cardiovascular disease due to increased cardiac risk. Patients with diabetes mellitus must have their glycemic control carefully monitored while using this medication.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Levothyroxine Sodium defines interactions primarily by altered absorption or modified systemic effects. The following table summarizes high-level interaction classifications documented by government authorities:

Classification Interacting Agents Official Interaction Outcome/Restriction
Absorption Interference Antacids (Aluminum, Magnesium), Iron/Calcium Salts, Bile Acid Sequestrants, Sucralfate Require at least 4 hours separation for administration to maintain Levothroid exposure.
Metabolic Alteration Enzyme Inducers (e.g., Rifampicin, Phenytoin), St. John’s Wort Increase hepatic clearance of Levothyroid, potentially increasing Levothroid requirements.
Pharmacodynamic Effect Oral Anticoagulants (e.g., Warfarin) Intensify the anticoagulant effect, which may increase the risk of bleeding.

Co-administration with Oral Estrogens (e.g., in contraceptives) may increase the Thyroxine-Binding Globulin (TBG) concentration, potentially necessitating a higher Levothroid requirement. The combination of Levothroid with Tyrosine Kinase Inhibitors may reduce hormone efficacy. Additionally, official labeling contraindicates the use of Levothroid, either alone or with other therapeutic agents, for the treatment of obesity or for weight loss due to the potential for serious toxicity. Elderly patients or those with underlying cardiovascular disease may have increased sensitivity to the effects of the Levothyroid and Anticoagulant interaction.

The regulatory documents define the product's interaction structure primarily through mandates for timing separation and constraints related to the modified requirements of co-administered agents like antidiabetics and anticoagulants.

Mechanism of Action

Levothroid ( T4) functions as a synthetic prohormone, requiring intracellular modification to exert its action. Within the target cell, T4 is converted by Deiodinase enzymes ( D2) into the active hormone, Triiodothyronine ( T3). T3 then acts as an agonist for the Nuclear Thyroid Hormone Receptors (TRs), which are located on the DNA. This binding initiates the transcription of specific genes, a process that fundamentally alters the cell’s production of regulatory proteins.

The resulting increase in protein synthesis leads to a systemic modulation of the Basal Metabolic Rate Pathway by influencing cellular oxygen consumption and energy expenditure. The mechanism also influences the function of the Cardiovascular System by increasing the expression of beta-adrenergic receptors and regulating calcium-handling proteins in heart muscle. These broad molecular changes support the regulation of cellular energy utilization and systemic metabolic function.

Because the drug's effect is primarily mediated by the slow cascade of gene transcription and new protein synthesis, the full physiological adjustment is inherently gradual, which determines its characteristic delayed onset. The mechanism is also constrained by the efficiency of cellular transporters and Deiodinase enzymes; if these steps are inhibited, the resulting physiological response is constrained.

Dosage and Administration Information

How Levothroid is used

Levothroid (levothyroxine sodium) is administered according to standardized principles. The method, dose, and frequency are dependent on the purpose of the treatment and the patient’s clinical profile.


Administration and Timing

Levothyroxine is primarily used as an Oral Tablet for chronic hormone replacement. The intravenous (IV Injection) formulation is reserved for the temporary management of acute, severe states, such as myxedema coma.

Feature Administration Guideline
Route & Frequency Oral: Single daily dose. IV: Short-term use, until oral therapy is tolerated.
Timing Relative to Meals Must be taken on an empty stomach, preferably one-half to one hour before breakfast.
Drug Separation Oral doses must be separated by at least 4 hours from drugs like calcium or iron supplements and antacids, which can interfere with absorption.
Pediatric Preparation For infants unable to swallow, tablets may be crushed and suspended in a small amount of water (5–10 mL) for immediate administration; the suspension must not be stored.

Dosing Rules

The required dose is determined individually based on age, body weight, and cardiovascular status. The maintenance dose for a healthy adult is typically calculated at approximately 1.6 micrograms per kilogram (mcg/kg) of body weight daily.

  • Dose Titration: Dosage adjustments are made in small increments, often 12.5 mcg or 25 mcg, at intervals of 4 to 6 weeks (or 6 to 8 weeks in cardiac patients) based on blood test results.
  • Population-Specific Starting Dose: In older adults (over 50) and patients with known cardiac disease, treatment should be initiated at a lower daily dose (12.5 mcg or 25 mcg) with slower titration to prevent adverse reactions.
  • Missed Dose: If a dose is missed, it should be taken as soon as remembered unless it is near the time of the next scheduled dose; patients should not take two doses at once.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Levothroid

Levothroid (levothyroxine sodium) is a medication that has been studied for many decades, with its research foundation including observational data and clinical trials. The evidence base is a mix of large-scale, long-term observational studies, where researchers monitor patient cohorts over time, and randomized controlled trials (RCTs) that focus on specific outcomes or patient groups. Understanding this research helps show what has been observed so far, according to official sources.


Evidence for Use in Primary Hypothyroidism

Research into Levothroid's use for primary hypothyroidism, a condition involving insufficient thyroid hormone, has utilized long-standing observational data and systematic reviews. Few modern trials compare this therapy to an inactive treatment (placebo) for the purpose of examining core measures of physiological response; instead, current research examines different formulations of the medication to ensure they are consistent.

Studies was observed in adult populations and focused on monitoring key biomarkers like Thyroid-Stimulating Hormone (TSH) and Free T4 (FT4). Data indicate patterns related to the measurement of these levels being maintained within a target range in observed patient cohorts. Findings indicate that research describes patterns related to TSH levels remaining within the target range in association with its use.


Evidence for Use in Subclinical Hypothyroidism

Subclinical hypothyroidism is a condition characterized by TSH levels that are slightly elevated while Free T4 levels remain within the normal range. Levothroid was evaluated in specific Randomized Controlled Trials (RCTs) for this use, including patient cohorts who presented with outcomes related to systemic or functional imbalance.

Research examined TSH normalization, changes in cardiovascular outcomes, and changes to lipid profiles. Findings were mixed and varied significantly across trials, particularly regarding whether treatment was associated with measured changes in non-specific symptoms or quality of life in all adults studied. Data show patterns related to normalizing the TSH biomarker, but certainty remains low regarding major clinical event outcomes observed in association with treatment.


What is Still Uncertain in Levothroid Research

Research continues to address specific areas where data are still emerging or certainty remains low.

  • Residual Symptoms: The core uncertainty relates to why a proportion of patients with primary hypothyroidism report residual or persistent symptoms, despite TSH levels falling within the target range after treatment.
  • Subclinical Benefit: Evidence quality varies across studies for subclinical hypothyroidism, and findings were mixed regarding patient-reported outcomes and cardiovascular event reduction.
  • Safety/Risk Balance in Suppression: For TSH suppression therapy after cancer, research is ongoing to balance the objective of keeping TSH low against the potential long-term cardiovascular risks associated with intentional over-replacement (subclinical hyperthyroidism).

Frequently Asked Questions (FAQ)

Common questions about Levothroid (FAQ)

Q: Is it true that I must take Levothroid exactly 30 minutes before breakfast?

The official administration guidelines recommend taking this medication on an empty stomach, preferably 30 to 60 minutes before breakfast. This timeframe is suggested to help ensure the body properly absorbs the active ingredient. Regulatory guidance suggests that maintaining consistency and separating the medication from food are important factors.


Q: Is it acceptable to take Levothroid at night instead of in the morning?

While taking it in the morning is common, official guidance indicates that taking it at night may be acceptable for some patients. If taken at night, it should be taken on a consistent, empty stomach. Guidance advises that this typically means separating it by at least 3 to 4 hours from the last meal of the day.


Q: What role do Free T4 and T3 tests play when monitoring Levothroid treatment?

Levothroid is a synthetic T4 hormone, which the body converts into the active hormone, T3. Therefore, the medication amount is typically adjusted based on the levels of Thyroid-Stimulating Hormone (TSH) and Free T4 (FT4) measured in the blood. These biomarkers help determine if the hormone replacement is supporting the body's metabolic function appropriately.


Q: Do pregnant individuals typically require a higher amount of Levothroid?

According to official product information, levothyroxine requirements often increase during pregnancy to maintain adequate thyroid hormone levels. This means that individuals who become pregnant while on the medication may require a higher amount compared to non-pregnant levels. Any amount adjustments are made based on laboratory results.


Q: Are there any reported long-term safety concerns regarding bone density or osteoporosis with Levothroid use?

Official warnings indicate that receiving an amount of the medication that results in over-replacement is associated with safety concerns. Over-replacement can lead to a decrease in bone mineral density, which may increase the risk of fractures, particularly in postmenopausal women.


Q: What should a patient do if they are considering starting a new herbal supplement while on Levothroid?

Official regulatory information states that certain herbal products may affect the metabolism or clearance of Levothroid in the body. For example, some products might increase the rate at which the drug is processed, which could potentially necessitate an evaluation of the required amount.


Q: Are generic levothyroxine products considered fully interchangeable with Levothroid?

Levothyroxine is classified as a narrow therapeutic index drug by the FDA, meaning small differences in the amount absorbed can significantly affect its performance. For this reason, stable blood concentrations are essential for treatment. Regulatory guidance emphasizes the importance of consistency in the specific levothyroxine product used.


Q: What is the process for crushing a Levothroid tablet for someone who cannot swallow pills?

For patients who cannot swallow the tablet whole, the official labeling provides instructions for preparation. The tablet may be crushed and suspended in a small amount of water (5 to 10 mL). The official instructions indicate that this mixture should be administered immediately, and the suspension is not to be stored for later use.


Q: What is the main difference between Levothroid and other levothyroxine brands?

All brand-name and generic levothyroxine products contain the same active ingredient, levothyroxine sodium (T4). The primary differences generally lie in the inactive ingredients (fillers) used in the tablet. Regulatory standards also focus on the consistency and stability of the active ingredient across different brands.


Q: Why is this medication sometimes used in people who have had thyroid cancer?

Levothroid serves a dual purpose in patients who have had thyroid cancer. It is used to replace the hormone missing after the thyroid gland is removed. Additionally, it is used in amounts designed to suppress TSH levels, which can help slow the growth of certain remaining cancer cells.


Q: How is Levothroid different from natural desiccated thyroid (NDT) medications?

Levothroid is a synthetic single-component therapy, providing only the T4 hormone (levothyroxine). The body then converts T4 into the active T3 hormone. In contrast, Natural Desiccated Thyroid (NDT) products are derived from animal sources and contain a combination of both T4 and T3 hormones.


Q: Do high-soy products, like tofu or soy milk, affect Levothroid?

Official warnings advise that soy products (including soy flour and soy formulas) can interfere by decreasing the amount of levothyroxine that is absorbed by the body. To maintain consistent absorption, an evaluation of the timing relative to consumption may be necessary.


Q: Is grapefruit or grapefruit juice known to interact with Levothroid?

According to official documents, grapefruit or grapefruit juice is listed as a food that may decrease the absorption of Levothroid. This interaction is documented as potentially reducing the amount of the drug the body takes in.


Q: Can coffee or caffeinated beverages affect the absorption of Levothroid?

Official guidance indicates that coffee can interfere with the absorption of levothyroxine. Consuming it too close to the time of administration may reduce the amount of drug taken in by the body, potentially leading to lower hormone levels.


Q: Does the use of Levothroid change if a person has Hashimoto's disease?

Hashimoto's thyroiditis is the most common cause of primary hypothyroidism for which this medication is prescribed. Levothroid replaces the missing hormone caused by the condition, and treatment is generally managed based on the resulting thyroid hormone levels.


Q: Does a person's weight impact the initial amount of Levothroid prescribed?

Yes, the required amount is determined on an individual basis. The maintenance amount for healthy adults is often initially calculated based on body weight in micrograms per kilogram ( mcg/kg). This initial amount is subject to adjustment based on follow-up laboratory results.


Q: If my TSH level is low, does that mean my Levothroid amount is too high?

A very low TSH level is typically the primary laboratory indicator that the body is receiving more thyroid hormone than needed. This state is known as therapeutic overdosage and is associated with adverse effects. The TSH level serves as a key indicator for assessing whether the replacement amount is appropriate.


Q: Does the list of interacting medicines include common over-the-counter painkillers?

Yes, official information lists certain salicylate pain relievers, such as aspirin, as non-prescription products that may interact with Levothroid. This potential interaction may change the amount of the drug required or affect the patient's condition.


Q: Is alcohol consumption known to cause negative interactions with Levothroid?

No direct interaction between alcohol and Levothroid is typically listed in official regulatory documentation focused on drug-to-drug interactions.


Q: Is hair loss a common temporary effect when first starting Levothroid?

Partial hair loss is a reported adverse reaction that can occur, particularly during the first few months of therapy. This effect is most often observed in children, and it is generally reported to be self-limiting.


Q: Are there any known serious, but rare, side effects mentioned in regulatory documents?

The official labeling includes serious warnings and precautions for cardiac complications such as arrhythmias and heart failure. Additionally, warnings exist for the potential of acute adrenal crisis if the medication is used in patients with an uncorrected adrenal insufficiency.


Q: If I lose weight after starting Levothroid, is that always a sign of a high amount?

While weight loss is listed as an adverse reaction related to therapeutic overdosage, it must be evaluated in the context of all laboratory results and symptoms. In clinical practice, close monitoring of thyroid levels is a key step to ensure the replacement amount is appropriate.


Q: How is Levothroid best stored at home to maintain its effectiveness?

Official storage guidelines require the medication be kept in a tightly closed container at controlled room temperature (20 C to 25 C). The tablets should be protected from heat, moisture, and light to maintain their effectiveness and stability, as instructed in the labeling.


Q: Does taking the medication help restore normal energy levels and reduce fatigue?

The medication is intended to replace the missing hormone, which is essential for normal metabolic function throughout the body. Hypothyroidism, the condition Levothroid treats, is commonly associated with systemic discomforts like fatigue and low energy.


Q: Does Levothroid treatment affect a person's fertility?

Proper thyroid hormone balance is officially recognized as essential for normal reproductive function. Conversely, untreated hypothyroidism is a condition that can impair fertility.


Q: Are there specific filler ingredients (like lactose or gluten) in the tablets matter?

The official labeling for levothyroxine products includes a full list of inactive ingredients, or fillers, which can contain substances like lactose or starch. For patients with dietary sensitivities, it is noted that one brand is specifically labeled as gluten-free.


Q: Does taking Levothroid impact other hormone levels in the body?

Yes, the medication is noted in official warnings to have effects on other hormone pathways. It can increase the metabolic clearance of glucocorticoids (adrenal hormones). It may also worsen glycemic control in patients with diabetes, which affects their insulin requirements.


Q: Is Levothroid considered a drug that needs to be avoided before surgery?

The medication is contraindicated in certain acute conditions, such as acute myocardial infarction or acute myocarditis. Patients are generally advised by official sources to inform all healthcare providers of all medications prior to any surgery or procedure.


Q: What is the typical follow-up schedule for blood testing once the amount is stable?

Once a stable level of thyroid hormone replacement has been established, annual monitoring of TSH levels is typically recommended for adults who are otherwise clinically stable.


Q: What is the difference in structure between Levothroid tablets and capsules?

Levothroid is manufactured as a standard oral tablet. While this product uses a tablet formulation, other levothyroxine products are available in capsule or liquid formulations. These different structures may be manufactured with different inactive ingredients and may have varying absorption characteristics.


Q: Why is consistency in taking the medication time so important?

The importance of consistency stems from the fact that levothyroxine is classified as a narrow therapeutic index drug. This means that stable blood concentrations are essential to ensure proper effectiveness and to minimize the risk of adverse effects.


Q: Is Levothroid generally considered safe for use in older adult populations?

The medication is used in older adults, but official warnings note that this population may have increased sensitivity and cardiac risk. This means treatment is typically initiated at a lower daily amount and is generally adjusted gradually.


Q: What other medical conditions can necessitate a change in the Levothroid amount?

Official regulatory documents state that the required amount may need to be adjusted due to several factors. These include starting or stopping certain medications or supplements, or changes in a patient's health status such as pregnancy or the worsening of a condition like diabetes.

How should Levothroid be stored and disposed of?

How to Store and Dispose of Levothroid: Official Requirements

Levothroid (levothyroxine sodium) must be stored according to strict regulatory guidelines to maintain its potency and stability.

Requirement Official Regulatory Statement
Storage Temperature Store at controlled room temperature (20 C to 25 C or 68 F to 77 F).
Protection Keep the container tightly closed and protect tablets from heat, moisture, and light. Do not store in high-humidity areas, such as a bathroom.
Stability After Prep Any suspension or mixture of crushed tablets must be administered immediately and cannot be stored for later use.
Child Safety Keep the medication out of the reach of children.

For disposal, utilize authorized drug take-back programs when available. If a take-back program is unavailable, dispose of the medication securely in the household trash, ensuring it is mixed with an undesirable substance. Do not flush Levothroid down the toilet or release it into the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Levothroid found in:

A-Z Index: